B. Oyan Et Al. , "Gallbladder perforation related to bevacizumab in a patient with lung adenocarcinoma.," 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , vol.31, Illinois, United States Of America, 2013
Oyan, B. Et Al. 2013. Gallbladder perforation related to bevacizumab in a patient with lung adenocarcinoma.. 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).
Oyan, B., Ozturk, M. A., & Kalayci, M., (2013). Gallbladder perforation related to bevacizumab in a patient with lung adenocarcinoma. . 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America
Oyan, BAŞAK, Mehmet Akif Ozturk, And Murat Kalayci. "Gallbladder perforation related to bevacizumab in a patient with lung adenocarcinoma.," 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2013
Oyan, BAŞAK O. Et Al. "Gallbladder perforation related to bevacizumab in a patient with lung adenocarcinoma.." 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2013
Oyan, B. Ozturk, M. A. And Kalayci, M. (2013) . "Gallbladder perforation related to bevacizumab in a patient with lung adenocarcinoma.." 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={BAŞAK OYAN ULUÇ Et Al. }, title={Gallbladder perforation related to bevacizumab in a patient with lung adenocarcinoma.}, congress name={49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2013}}